New paradigms/therapies in relapsed/refractory disease: From small molecules to monoclonal antibodies

New paradigms/therapies in relapsed/refractory disease: From small molecules to monoclonal antibodies

HMP CME

3 years
460 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from Lymphoma & Myeloma 2016, Dr. Kenneth C. Anderson discusses new paradigms and therapies in the treatment of relapsed/refractory myeloma, with an emphasis on small molecules and monoclonal antibodies. Earn CME credit for a related activity at the following location: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7225 © 2016 Imedex, LLC.
Up Next Autoplay